MARY ROMAIN: Open Payments
NPI 1598085169 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 26 payments from 15 companies in 2025. Trend: 2023 $695 · 2024 $850 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 4 | $225 |
| Janssen Biotech, Inc. | 3 | $189 |
| Calyxo, Inc. | 1 | $97 |
| UROGEN PHARMA, INC. | 3 | $85 |
| Boston Scientific Corporation | 2 | $61 |
| Sumitomo Pharma America, Inc. | 3 | $51 |
| DENTSPLY IH AB | 2 | $41 |
| Endo USA, Inc. | 1 | $30 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Teleflex LLC | 1 | $25 |
Products named: ADSTILADRIN, ERLEADA, CVAC ASPIRATION SYSTEM, RYBREVANT, LithoVue, ZUSDURI, GEMTESA, LOFRIC.
Industry payments across FL — which companies pay providers there.
